Close

Pernix Therapeutics Inc. to Present at JMP Securities Life Sciences Conference

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SPY
5. INFY
6. SNV
7. TSLA
8. SMCI
9. SLB
10. PPG


June 15, 2015 5:30 PM EDT

MORRISTOWN, N.J., June 15, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (Nasdaq: PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and Chief Executive Officer, and Sanjay Patel, Chief Financial Officer, are scheduled to present at the JMP Securities Life Sciences Conference as follows:

Date: Tuesday, June 23, 2015
Time: 1:00 p.m. EDT
Location: The St. Regis New York

The presentation will be webcast and available on the Investors section of the Company's website at http://www.pernixtx.com/investors/webcasts-presentations/. A replay of the webcast will be available for 30 days after the date of the presentation.

About Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its two Pernix sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc. To learn more about Pernix Therapeutics, visit www.pernixtx.com.

CONTACT: Investor Relations
         Lisa Wilson, (212) 452-2793
         In-Site Communications
         [email protected]

         Media Relations
         Marianne Lambertson, (800) 793-2145 ext. 1012
         Vice President, Marketing & Corporate Communications
         [email protected]

Source: Pernix Therapeutics, Inc.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

JMP Securities